Home » Topics » Regulatory

Regulatory
RSS

Expanded FDA approvals for Opdivo + Yervoy and single-agent Opdivo in melanoma

Jan. 25, 2016

UCB's Briviact approved in E.U. as adjunctive treatment for partial-onset seizures

Jan. 22, 2016

FDA approves Neulasta to treat radiation sickness

Jan. 21, 2016

SK Chemicals' SKY Cellflu Quadrivalent approved in South Korea

Dec. 29, 2015

FDA approves AstraZeneca's Zurampic for hyperuricemia in gout

Dec. 23, 2015

FDA approves Uptravi for pulmonary arterial hypertension

Dec. 22, 2015

FDA approves Keytruda for first-line treatment of unresectable or metastatic melanoma

Dec. 21, 2015

FDA approves Otiprio for pediatric patients undergoing tympanostomy tube placement

Dec. 14, 2015

FDA approves Vistogard to treat overdose or severe toxicities due to 5-FU or capecitabine

Dec. 14, 2015

Biocad's biosimilar bevacizumab approved in Russia

Dec. 11, 2015

Popular Stories

Today's news in brief
BioWorld
BioWorld briefs for July 3, 2025.
Today's news in brief
BioWorld MedTech
BioWorld MedTech briefs for July 3, 2025.
Researchers arm CAR T cells to fight solid tumors
BioWorld
Aussie researchers have used CRISPR gene editing tools to “armor” chimeric antigen receptor (CAR) T cells to activate additional cancer-fighting proteins at the...
Bioversys, Shionogi in CHF529M lung infection collaboration
BioWorld Science
Antibiotics specialist Bioversys AG has sealed a potential CHF529 million (US$667.5 million) deal with Shionogi Co. Ltd., in which they will work together on...
Medtronic receives CE mark for its Vitalflow ECMO system
BioWorld MedTech
Medtronic plc received a CE mark for its Vitalflow extracorporeal membrane oxygenation (ECMO) system, which provides temporary support for the heart and lungs in...